Filing Details

Accession Number:
0001415889-24-018407
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-28 16:06:40
Reporting Period:
2024-06-26
Accepted Time:
2024-06-28 16:06:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1786205 Arcellx Inc. ACLX Biological Products, (No Disgnostic Substances) (2836) 472855917
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1930862 Michelle Gilson C/O Arcellx, Inc.
800 Bridge Parkway
Redwood City CA 94065
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-26 12,326 $53.68 7,466 No 4 S Direct
Common Stock Disposition 2024-06-26 551 $54.25 6,915 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 18, 2023 and subsequently modified March 27, 2024.
  2. Represents the weighted average share price of an aggregate total of 12,326 shares sold in the price range of $53.18 to $54.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 551 shares sold in the price range of $54.18 to $54.44 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.